MHRA authorises plozasiran (Redemplo) for adults with familial chylomicronaemia syndrome

The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 19 October 2026, authorised plozasiran (Redemplo)

Leave a Reply

Your email address will not be published.